BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10613922)

  • 1. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line.
    Kunath K; Kopecková P; Minko T; Kopecek J
    Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line.
    Minko T; Kopecková P; Pozharov V; Kopecek J
    J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
    Omelyanenko V; Kopecková P; Gentry C; Kopecek J
    J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells.
    Minko T; Kopecková P; Kopecek J
    Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro.
    Omelyanenko V; Gentry C; Kopecková P; Kopecek J
    Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line.
    Minko T; Kopecková P; Kopecek J
    J Control Release; 1999 May; 59(2):133-48. PubMed ID: 10332049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
    Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
    J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments.
    Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J
    Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells.
    Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J
    Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts.
    Shiah JJ; Sun Y; Peterson CM; Kopecek J
    J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates.
    Tijerina M; Kopecková P; Kopecek J
    Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates.
    Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of the chemotherapeutic action of HPMA copolymer-bound doxorubicin in a solid tumor model of ovarian carcinoma.
    Minko T; Kopecková P; Kopecek J
    Int J Cancer; 2000 Apr; 86(1):108-17. PubMed ID: 10728603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect.
    Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B
    Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic exposure of human ovarian carcinoma cells to free or HPMA copolymer-bound mesochlorin e6 does not induce P-glycoprotein-mediated multidrug resistance.
    Tijerina M; Fowers KD; Kopecková P; Kopecek J
    Biomaterials; 2000 Nov; 21(21):2203-10. PubMed ID: 10985494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy and photodynamic therapy with N-(2-hydroxypropyl) methacrylamide copolymer-bound anticancer drugs inhibit human ovarian carcinoma heterotransplanted in nude mice.
    Peterson CM; Lu JM; Sun Y; Peterson CA; Shiah JG; Straight RC; Kopecek J
    Cancer Res; 1996 Sep; 56(17):3980-5. PubMed ID: 8752167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biorecognition of HPMA copolymer-adriamycin conjugates by lymphocytes mediated by synthetic receptor binding epitopes.
    Omelyanenko V; Kopecková P; Prakash RK; Ebert CD; Kopecek J
    Pharm Res; 1999 Jul; 16(7):1010-9. PubMed ID: 10450924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
    Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymerizable Fab' antibody fragments for targeting of anticancer drugs.
    Lu ZR; Kopecková P; Kopecek J
    Nat Biotechnol; 1999 Nov; 17(11):1101-4. PubMed ID: 10545917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.